Why the study?
Does calculated plasma volume status (PVS) predict mortality and morbid events in patients with chronic heart failure?
Population
119 normal subjects, 30 CHF patients, 5002 patients from the Val-HeFT trial, and 246 routine CHF outpatients
Design
Cohort
Follow-up
2 years
Authors
Loading...
PVS may refine mortality risk stratification in chronic HF; hypothesis-generating pending prospective validation.
Does calculated plasma volume status (PVS) predict mortality and morbid events in patients with chronic heart failure?
Calculated relative plasma volume status (PVS) from simple clinical indices independently predicts mortality and morbid events in chronic heart failure patients.
Ling et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: